Evolus Short Term Debt vs Cash Analysis
EOLS Stock | USD 13.59 0.11 0.80% |
Evolus financial indicator trend analysis is much more than just examining Evolus Inc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evolus Inc is a good investment. Please check the relationship between Evolus Short Term Debt and its Cash accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Short Term Debt vs Cash
Short Term Debt vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evolus Inc Short Term Debt account and Cash. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Evolus' Short Term Debt and Cash is -0.45. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Cash in the same time period over historical financial statements of Evolus Inc, assuming nothing else is changed. The correlation between historical values of Evolus' Short Term Debt and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Evolus Inc are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Short Term Debt i.e., Evolus' Short Term Debt and Cash go up and down completely randomly.
Correlation Coefficient | -0.45 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Short Term Debt
Cash
Cash refers to the most liquid asset of Evolus Inc, which is listed under current asset account on Evolus Inc balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Evolus customers. The amounts must be unrestricted with restricted cash listed in a different Evolus account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Evolus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evolus Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Evolus' Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.91 in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
Evolus fundamental ratios Correlations
Click cells to compare fundamentals
Evolus Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evolus fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 240.4M | 209.1M | 257.5M | 178.0M | 189.0M | 190.3M | |
Short Long Term Debt Total | 96.5M | 138.3M | 74.7M | 73.2M | 126.5M | 103.1M | |
Other Current Liab | 17.4M | 72.9M | 42.4M | 2.4M | 31.6M | 21.2M | |
Total Current Liabilities | 24.4M | 180.2M | 57.7M | 46.5M | 48.3M | 61.0M | |
Total Stockholder Equity | (213.1M) | (376.1M) | (422.9M) | 18.5M | (20.7M) | (21.7M) | |
Other Liab | 59.1M | 58.1M | 44.5M | 39.9M | 45.9M | 46.9M | |
Net Tangible Assets | (1.4M) | (149.5M) | 10.0M | (51.3M) | (59.0M) | (62.0M) | |
Net Debt | (13.3M) | 35.8M | (71.5M) | 19.3M | 63.7M | 66.9M | |
Retained Earnings | (213.1M) | (376.1M) | (422.9M) | (497.3M) | (559.0M) | (531.0M) | |
Accounts Payable | 5.8M | 9.6M | 6.1M | 33.7M | 4.3M | 7.9M | |
Cash | 109.9M | 102.6M | 146.3M | 53.9M | 62.8M | 70.0M | |
Non Current Assets Total | 88.2M | 81.5M | 78.7M | 77.2M | 76.6M | 63.4M | |
Common Stock Shares Outstanding | 28.2M | 33.7M | 49.8M | 56.1M | 56.9M | 37.9M | |
Liabilities And Stockholders Equity | (52.1M) | (94.0M) | (247.3M) | 178.0M | 189.0M | 198.4M | |
Non Current Liabilities Total | 136.5M | 101.8M | 117.9M | 113.0M | 161.4M | 94.2M | |
Other Current Assets | 5.3M | 7.0M | 11.0M | 5.6M | 8.1M | 5.2M | |
Total Liab | 161.0M | 282.0M | 175.6M | 159.5M | 209.7M | 178.1M | |
Total Current Assets | 152.2M | 127.6M | 178.8M | 100.8M | 112.4M | 103.1M | |
Intangible Assets | 59.6M | 55.3M | 50.6M | 48.6M | 47.1M | 43.2M | |
Non Currrent Assets Other | 2.4M | 240K | 2.8M | 2.8M | 409.0K | 388.5K | |
Other Assets | 2.4M | 3.7M | 32.5M | 2.8M | 1.0 | 0.95 | |
Net Invested Capital | 170.9M | 61M | 153.1M | 90.4M | 99.7M | 92.8M | |
Net Working Capital | 127.8M | (52.6M) | 121.1M | 54.3M | 64.1M | 41.5M | |
Long Term Debt | 91.5M | 40.5M | 71.2M | 71.9M | 120.4M | 75.6M | |
Cash And Short Term Investments | 129.8M | 107.6M | 146.3M | 53.9M | 62.8M | 79.1M |
Pair Trading with Evolus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will appreciate offsetting losses from the drop in the long position's value.Moving together with Evolus Stock
0.79 | VRDN | Viridian Therapeutics | PairCorr |
0.87 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Evolus Stock
0.5 | STOK | Stoke Therapeutics | PairCorr |
0.46 | DSGN | Design Therapeutics | PairCorr |
The ability to find closely correlated positions to Evolus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolus Inc to buy it.
The correlation of Evolus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Evolus Stock analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Evolus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolus. If investors know Evolus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.04) | Revenue Per Share 3.821 | Quarterly Revenue Growth 0.422 | Return On Assets (0.11) | Return On Equity (4.73) |
The market value of Evolus Inc is measured differently than its book value, which is the value of Evolus that is recorded on the company's balance sheet. Investors also form their own opinion of Evolus' value that differs from its market value or its book value, called intrinsic value, which is Evolus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolus' market value can be influenced by many factors that don't directly affect Evolus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.